Phoenix Group (OTCMKTS:PNXGF – Get Rating) had its target price cut by JPMorgan Chase & Co. from GBX 665 ($8.10) to GBX 655 ($7.98) in a research report sent to investors on Tuesday morning, The Fly reports.
PNXGF has been the topic of several other reports. Deutsche Bank Aktiengesellschaft boosted their target price on Phoenix Group from GBX 680 ($8.29) to GBX 720 ($8.78) in a research note on Tuesday, January 10th. Peel Hunt upgraded Phoenix Group to a hold rating in a research report on Tuesday, January 31st. Barclays lifted their price target on Phoenix Group from GBX 788 ($9.60) to GBX 790 ($9.63) in a research report on Tuesday, November 22nd. UBS Group upgraded Phoenix Group from a neutral rating to a buy rating in a research report on Tuesday, November 15th. Finally, Berenberg Bank lifted their price target on Phoenix Group from GBX 815 ($9.93) to GBX 820 ($9.99) in a research report on Tuesday, January 31st. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of Hold and an average target price of $720.71.
Phoenix Group Stock Performance
Shares of PNXGF opened at $7.65 on Tuesday. The stock’s fifty day moving average price is $7.92 and its two-hundred day moving average price is $7.01. Phoenix Group has a 1 year low of $6.00 and a 1 year high of $8.28.
Phoenix Group Company Profile
Phoenix Group Holdings Plc operates as a life and pensions consolidator. The firm specializes in the acquisition and management of closed life insurance and pension funds. It operates through the following segments: UK Heritage, UK Open, Europe, Management Services, and Unallocated Group. The UK Heritage contains United Kingdom businesses which no longer actively sell products to policyholders and which therefore run-off gradually over time.
Read More
- Get a free copy of the StockNews.com research report on Phoenix Group (PNXGF)
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts DefendĀ
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for Phoenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phoenix Group and related companies with MarketBeat.com's FREE daily email newsletter.